Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship Between 18F-fluorodeoxyglucose Accumulation and the BRAF V600E Mutation in Papillary Thyroid Cancer.

World journal of surgery - 1 Jan 2018

Chang Jae Won, Park Ki Wan, Heo Jae Hyung, Jung Seung-Nam, Liu Lihua, Kim Sung Min, Kwon In Sun, Koo Bon Seok

Abstract excerpt

BACKGROUND: To determine whether 18F-fluoro-2-deoxyglucose (18F-FDG)-PET/CT is useful for predicting the BRAF V600E mutation status of a primary papillary thyroid carcinoma (PTC). METHODS: A retrospective analysis was performed in 108 patients who underwent 18F-FDG positron emission tomography-computed tomography (PET/CT) for staging before thyroidectomy and BRAF analysis in biopsy-confirmed PTC. The maximum...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Positron Emission Tomography Computed Tomography

Share to Radiopharmaceuticals

Share to ROC Curve

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 28808756
DOI: 10.1007/s00268-017-4136-y

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship Between 18F-fluorodeoxyglucose Accumulation and the BRAF V600E Mutation in Papillary Thyroid Cancer.PMID 28808756Read ↗

Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer.Semantic proximity Read ↗

Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.Semantic proximity Read ↗

Correlation of BRAF mutation and SUVmax levels in thyroid cancer patients incidentally detected in 18F-fluorodeoxyglucose positron emission tomography.Semantic proximity Read ↗

THE RELATIONSHIP OF BRAFV600E MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS.Semantic proximity Read ↗

FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?Semantic proximity Read ↗

PET/CT in thyroid cancer - the importance of BRAF mutations.Semantic proximity Read ↗

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study.Semantic proximity Read ↗

Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas.Semantic proximity Read ↗

Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma.Semantic proximity Read ↗

The BRAF V600E mutation in papillary thyroid carcinoma is associated with glucose transporter 1 overexpression.Semantic proximity Read ↗

Correlation between the BRAF V600E mutation status and the clinicopathologic features of papillary thyroid carcinoma.Semantic proximity Read ↗

The association between BMI and BRAFV600E mutation may differ by primary tumor size.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.